Journal: Journal of the Endocrine Society
Article Title: Transgender Women With Suppressed Testosterone Display Lower Burden of Coronary Disease Than Matched Cisgender Men
doi: 10.1210/jendso/bvae120
Figure Lengend Snippet: Biomarker concentrations
Article Snippet: Soluble CD14 (sCD14, R and D Systems catalog No. DC140, RRID:AB_3095885), soluble CD163 (sCD163, R and D Systems catalog No. DC1630, RRID:AB_3096052), interleukin-6 (IL-6, R and D Systems catalog No. HS600C, RRID:AB_2893335), fatty acid-binding protein-4 (FABP-4, (ImmunoDiagnostics catalog No. 31030, RRID:AB_2933962), high-molecular-weight adiponectin (R and D Systems catalog No. DRP300, RRID:AB_2783020), insulin (R and D Systems catalog No. DINS00, RRID:AB_3073852), endothelin-1 (ET-1, R and D Systems catalog No. DET100, RRID:AB_3099470), and vascular cell adhesion molecule-1 (VCAM-1, R and D Systems catalog No. DVC00, RRID:AB_2941366) were analyzed by Quantikine ELISA (enzyme-linked immunosorbent assay), and soluble tumor necrosis factor receptor type (sTNFR, R and D Systems catalog No. LUCAM726, RRID:AB_3099473) I/II, interleukin-8 (IL-8, R and D Systems catalog No. DY208, RRID:AB_2892143), and plasminogen activator inhibitor-1 (PAI-1, R and D Systems catalog No. LOBM1786, RRID:AB_3099472) were measured by Luminex assay.
Techniques: Biomarker Assay